SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001618835-19-000096
Filing Date
2019-06-05
Accepted
2019-06-05 17:07:19
Documents
3
Period of Report
2019-06-05
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K evfm8-k2019annualmeetingre.htm 8-K 49964
2 EXHIBIT 10.1 exhibit101amendedandrestat.htm EX-10.1 254100
3 EXHIBIT 10.2 exhibit1022019espp.htm EX-10.2 56936
  Complete submission text file 0001618835-19-000096.txt   362409
Mailing Address 12400 HIGH BLUFF DRIVE SUITE 600 SAN DIEGO CA 92130
Business Address 12400 HIGH BLUFF DRIVE SUITE 600 SAN DIEGO CA 92130 (858) 550-1900
Evofem Biosciences, Inc. (Filer) CIK: 0001618835 (see all company filings)

IRS No.: 208527075 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36754 | Film No.: 19880542
SIC: 2834 Pharmaceutical Preparations